The problem of choosing between the original and of generic drugs in patients with overweight and obesity

Abstract

This review article discusses the similarities and differences in the research, production and use in clinical practice, original and generic drugs. Reproduced drugs (generics) present on the Russian pharmaceutical market that have the bioequivalence data are not always equal in therapeutic equivalence of the original drug. The article presents evidence base of efficacy and safety of the original drug Xenical in the complex treatment of patients with overweight and obesity.

Keywords

• obesity
• orlistat
• xenical
• generic drugs
• generic drugs
• overweight
• bioequivalence
• therapeutic equivalence